Friedemann Paul group

Paul Lab

Clinical Neuroimmunology

Our focus is upon the improvement of the therapeutic and diagnostic possibilities for neuroimmunological diseases, especially for multiple sclerosis.

We are working on this with a translational approach; this means that we try to transfer new developments and findings from basic research directly into clinical work.

Further information on our website

Publications

in Mult Scler Relat Disord

MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder

R. Narayan et al.
in PLoS ONE

Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging

S. Chawla et al.
in EPMA J

Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies

N. Borisow et al.
in JAMA Neurol

Association of retinal ganglion cell layer thickness with future disease activity in patients with clinically isolated syndrome

H.G. Zimmermann et al.
in Neurol Neuroimmunol Neuroinflamm

Temporal visual resolution and disease severity in MS

N. Ayadi et al.
in Neurol Neuroimmunol Neuroinflamm

VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab

M. Pawlitzki et al.
in PLoS ONE

Objective assessment of a relative afferent pupillary defect by B-mode ultrasound

F.A. Schmidt et al.
in Acta Neurol Scand

Optical coherence tomography in acute optic neuritis: a population-based study

K. Soelberg et al.
in Mult Scler J

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis

M. Weygandt et al.
in Ann Clin Transl Neurol

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions

J.R. Behrens et al.
Friedemann Paul

Kontakt

 

Prof. Dr. Friedemann Paul

friedemann.paul@charite.de

 

Experimental and Clinical Research Center
Lindenberger Weg 80
13125 Berlin